VA tests 'Nudge' to boost lifesaving heart failure prescriptions
NCT ID NCT05986695
First seen May 13, 2026 · Last updated Jun 21, 2026 · Updated 10 times
Summary
This study tested whether simple nudges—like an alert in a doctor's daily task list or an email comparing their prescribing habits to peers—could increase the use of two types of heart failure medications (SGLT2 inhibitors and MRAs) that are proven to save lives but are often underused. Researchers enrolled 81 primary care and cardiology clinicians at a single VA hospital. The goal was to see if these gentle reminders could help more eligible veterans get the right prescriptions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Southern Arizona VA Health Care System, Tucson, AZ
Tucson, Arizona, 85723-0001, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
behavioral intervention (informational alert and peer comparison report)
What this could lead to
If successful, this approach could increase use of proven heart failure medications, potentially reducing hospitalizations and saving lives among veterans.
What could go wrong
This is a small, early implementation study with only 81 clinicians at one VA site, so results may not apply broadly. The intervention is a nudge, not a new drug, so its impact may be modest.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.